Cargando…

Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development

Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule suscep...

Descripción completa

Detalles Bibliográficos
Autores principales: Staśkiewicz, Agnieszka, Ledwoń, Patrycja, Rovero, Paolo, Papini, Anna Maria, Latajka, Rafal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172596/
https://www.ncbi.nlm.nih.gov/pubmed/34095086
http://dx.doi.org/10.3389/fchem.2021.674705
_version_ 1783702563075391488
author Staśkiewicz, Agnieszka
Ledwoń, Patrycja
Rovero, Paolo
Papini, Anna Maria
Latajka, Rafal
author_facet Staśkiewicz, Agnieszka
Ledwoń, Patrycja
Rovero, Paolo
Papini, Anna Maria
Latajka, Rafal
author_sort Staśkiewicz, Agnieszka
collection PubMed
description Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule susceptibility to enzymatic degradation, reduction, hydrolysis, and oxidation. In fact, peptides containing triazole rings are a typical example of peptidomimetics. They have all the advantages over classic peptides. Both efficient synthetic methods and biological activity make these systems an interesting and promising object of research. Peptide triazole derivatives display a diversity of biological properties and can be obtained via numerous synthetic strategies. In this review, we have highlighted the importance of the triazole-modified peptidomimetics in the field of drug design. We present an overview on new achievements in triazolyl-containing peptidomimetics synthesis and their biological activity as inhibitors of enzymes or against cancer, viruses, bacteria, or fungi. The relevance of above-mentioned compounds was confirmed by their comparison with unmodified peptides.
format Online
Article
Text
id pubmed-8172596
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81725962021-06-04 Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development Staśkiewicz, Agnieszka Ledwoń, Patrycja Rovero, Paolo Papini, Anna Maria Latajka, Rafal Front Chem Chemistry Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule susceptibility to enzymatic degradation, reduction, hydrolysis, and oxidation. In fact, peptides containing triazole rings are a typical example of peptidomimetics. They have all the advantages over classic peptides. Both efficient synthetic methods and biological activity make these systems an interesting and promising object of research. Peptide triazole derivatives display a diversity of biological properties and can be obtained via numerous synthetic strategies. In this review, we have highlighted the importance of the triazole-modified peptidomimetics in the field of drug design. We present an overview on new achievements in triazolyl-containing peptidomimetics synthesis and their biological activity as inhibitors of enzymes or against cancer, viruses, bacteria, or fungi. The relevance of above-mentioned compounds was confirmed by their comparison with unmodified peptides. Frontiers Media S.A. 2021-05-20 /pmc/articles/PMC8172596/ /pubmed/34095086 http://dx.doi.org/10.3389/fchem.2021.674705 Text en Copyright © 2021 Staśkiewicz, Ledwoń, Rovero, Papini and Latajka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Staśkiewicz, Agnieszka
Ledwoń, Patrycja
Rovero, Paolo
Papini, Anna Maria
Latajka, Rafal
Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title_full Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title_fullStr Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title_full_unstemmed Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title_short Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
title_sort triazole-modified peptidomimetics: an opportunity for drug discovery and development
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172596/
https://www.ncbi.nlm.nih.gov/pubmed/34095086
http://dx.doi.org/10.3389/fchem.2021.674705
work_keys_str_mv AT staskiewiczagnieszka triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment
AT ledwonpatrycja triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment
AT roveropaolo triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment
AT papiniannamaria triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment
AT latajkarafal triazolemodifiedpeptidomimeticsanopportunityfordrugdiscoveryanddevelopment